Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$6.39 - $8.8 $104,425 - $143,809
-16,342 Reduced 87.93%
2,244 $0
Q3 2022

Oct 26, 2022

BUY
$7.99 - $10.75 $3,987 - $5,364
499 Added 2.76%
18,586 $160,000
Q2 2022

Jul 25, 2022

SELL
$4.58 - $17.13 $40,065 - $149,853
-8,748 Reduced 32.6%
18,087 $149,000
Q1 2022

May 02, 2022

BUY
$12.3 - $18.33 $56,703 - $84,501
4,610 Added 20.74%
26,835 $445,000
Q4 2021

Jan 28, 2022

BUY
$7.44 - $16.72 $165,354 - $371,602
22,225 New
22,225 $371,000

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $446M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.